ArticleThe World Allergy Organization journal2026

Efficacy and acceptability of lanadelumab for long-term prophylaxis in hereditary angioedema: A Chinese multicenter real-world analysis.

Yijing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.